Trump Imposes New US Tariffs on Drone Imports Over National Security Concerns 
Gold Prices Rise as Weak US Data and Hormuz Risks Boost Safe-Haven Demand 
Antofagasta Shares Drop 5% as Miner Cuts 2026 Copper Production Forecast 
Japan Economy Grows 1.1% in Q2 as Consumer Spending Stalls 
Google Pushes Gemini AI Overhaul as Sergey Brin Targets Model Supremacy 
Asian Stocks Steady as Iran War Keeps Oil Prices and Inflation Risks Elevated 
US Stock Futures Steady as Cooling Inflation and Strong Earnings Support Markets 
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback 
Nvidia’s $500 Billion AI Infrastructure Push Wins Morgan Stanley Support 
Yen Edges Higher as Weak US Data Dampens Fed Rate Hike Expectations 
J.P. Morgan Upgrades SanDisk, Sets $2,250 Price Target on AI NAND Growth 
Paramount Skydance Clears Regulatory Hurdles for Warner Bros. Discovery Deal 
Australia’s Corporate Leaders Face Parliament Over KPMG Client Data Scandal 
Oil Prices Fall as U.S. Crude Inventories Surge and Hormuz Tensions Persist 
European Stocks Steady as U.S.-Iran War, Euro Zone Data Keep Investors Cautious 
Add as a preferred source on Google
Lotte Biologics is reportedly accused of stealing the trade secrets of its rival, Samsung Biologics. A probe into the case was already launched by prosecutors, and officials will be especially checking into some of the company’s employees who were suspected of the crime.
According to The Korea Times, the Incheon District Prosecutors' Office dispatched investigators last week to search the headquarters of Lotte Biologics located in Seoul’s Lotte World Tower. The raid took place on Friday, Oct. 7, and during the search, authorities said they were able to secure the computers of three former workers who were revealed to have moved from Samsung Biologics to Lotte Biologics, but their job positions in the company were not revealed.
Prior to the investigation, it was reported that Samsung Biologics filed to apply for a court directive for the infringement of its company trade secrets in May. In the application for the injunction, it mentioned its three former employees who moved to Lotte Biologics in July.
While their job roles were not disclosed, the three people were said to have work duties related to Samsung Biologics’ core business. The trio was also said to have printed a large number of company documents before transferring to its rival firm, Lotte Biologics.
The Incheon District Court responded to the application by granting Lotte’s request and issuing an injunction against the infringement of trade secrets that were filed by Samsung’s biotechnology business unit on July 29. The directive was to prevent the leak of any business secrets that could be utilized by Lotte Biologics for its benefit.
"We cannot reveal the specifics of the investigation including the search and seizure," the prosecution body commented with regard to the recent raid at the Lotte Biologics HQ
Meanwhile, the biological CDMO (Contract Development Manufacturing Organization) division of the Lotte Group was said to have started hiring bio professionals in the last quarter of 2021 as it was preparing to jump into the bio business. Based on the reports, many of the new hires were recruited from Samsung Biologics.
